Login
欢迎浏览恩派尔生物资料网
我要投稿 请登录 免费注册 安全退出

您现在的位置是: 首页 > 实验方法 > 细胞技术

细胞技术

Local Application of Antisense for Prevention of Restenosis

2025-02-25 细胞技术 加入收藏
In 1977, percutaneous transluminal coronary angioplasty (PTCA) was first introdu

In 1977, percutaneous transluminal coronary angioplasty (PTCA) was first introduced (1 ), and it has become an effective treatment for limited coronary artery disease (2 ). PTCA treatment has since become more extensive and gained favor as an alternative treatment for coronary artery bypass grafting (3 ). The artery is injured at the site of PTCA, leading to wound healing responses including thrombosis, smooth muscle proliferation and migration, elastic recoil, and vascular remodeling. Each of these responses may contribute to recurrent obstruction or vessel narrowing, referred to as restenosis.

文章底部广告位

文章评论

加载中~